CXCL13 as a biomarker in the diagnostics of European lyme Neuroborreliosis - A prospective multicentre study in Austria.

MLA

Waiß, Christoph, et al. “CXCL13 as a Biomarker in the Diagnostics of European Lyme Neuroborreliosis - A Prospective Multicentre Study in Austria.” Journal of Central Nervous System Disease, May 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1177/11795735241247026.

APA

Waiß, C., Ströbele, B., Graichen, U., Klee, S., Gartlehner, J., Sonntagbauer, E., Hirschbichler, S., Tinchon, A., Kacar, E., Wuchty, B., Novotna, B., Kühn, Z., Sellner, J., Struhal, W., Bancher, C., Schnider, P., Asenbaum-Nan, S., & Oberndorfer, S. (2024). CXCL13 as a biomarker in the diagnostics of European lyme Neuroborreliosis - A prospective multicentre study in Austria. Journal of Central Nervous System Disease, 1–9. https://doi.org/10.1177/11795735241247026

Chicago

Waiß, Christoph, Barbara Ströbele, Uwe Graichen, Sascha Klee, Joshua Gartlehner, Estelle Sonntagbauer, Stephanie Hirschbichler, et al. 2024. “CXCL13 as a Biomarker in the Diagnostics of European Lyme Neuroborreliosis - A Prospective Multicentre Study in Austria.” Journal of Central Nervous System Disease, May, 1–9. doi:10.1177/11795735241247026.